文献速递淋巴瘤

慢性淋巴细胞白血病全基因组测序揭示IgHV突变型与未突变型亚组间突变景观的显著差异

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.
PubMed 文献 · Leukemia · 2017-06-06

该研究对46例慢性淋巴细胞白血病(CLL)患者进行全基因组测序,系统比较IgHV突变型与未突变型在编码和非编码单核苷酸变异、拷贝数变异、结构变异、kataegis区域及突变特征上的差异。研究发现约四分之一位于Ig基因座外kataegis区域的非编码突变位于CLL相关基因中,ATM非编码突变可能负向影响ATM表达,并在TCL1A及IgHV未突变型CLL的IKZF3、SAMHD1、PAX5和BIRC3中发现非编码和调控区突变。IgHV未突变型CLL以驱动基因编码突变和衰老特征为主,而IgHV突变型CLL则高发由异常活化诱导胞苷脱氨酶活性引起的启动子和增强子突变。

要点

  • IgHV未突变型CLL以驱动基因编码突变和衰老特征为主。
  • IgHV突变型CLL高发由异常AID活性引起的启动子和增强子突变。
  • Ig基因座外kataegis区域约四分之一非编码突变位于CLL相关基因。

核心结论

  • 两个亚组间临床结局和生物学特征的差异可能反映突变分布、发生率和不同潜在突变机制的差异。

研究设计与样本

  • 对46例CLL患者进行全基因组测序,系统比较IgHV突变型与未突变型在编码和非编码单核苷酸变异、拷贝数变异、结构变异、kataegis区域及突变特征上的差异。

主要发现

  • Ig基因座外kataegis区域约四分之一非编码突变位于CLL相关基因。
  • ATM非编码突变可能负向影响ATM表达。
  • 在TCL1A以及IgHV未突变型CLL的IKZF3、SAMHD1、PAX5和BIRC3中发现非编码和调控区突变。
  • IgHV未突变型CLL以驱动基因编码突变和衰老特征为主。
  • IgHV突变型CLL高发由异常活化诱导胞苷脱氨酶活性引起的启动子和增强子突变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lymphocytic leukaemia (CLL) consists of two biologically and clinically distinct subtypes defined by the abundance of somatic hypermutation (SHM) affecting the Ig variable heavy-chain locus (IgHV). The molecular mechanisms underlying these subtypes are incompletely understood. Here, we present a comprehensive whole-genome sequencing analysis of somatically acquired genetic events from 46 CLL patients, including a systematic comparison of coding and non-coding single-nucleotide variants, copy number variants and structural variants, regions of kataegis and mutation signatures between IgHVmut and IgHVunmut subtypes. We demonstrate that one-quarter of non-coding mutations in regions of kataegis outside the Ig loci are located in genes relevant to CLL. We show that non-coding mutations in ATM may negatively impact on ATM expression and find non-coding and regulatory region mutations in TCL1A, and in IgHVunmut CLL in IKZF3, SAMHD1,PAX5 and BIRC3. Finally, we show that IgHVunmut CLL is dominated by coding mutations in driver genes and an aging signature, whereas IgHVmut CLL has a high incidence of promoter and enhancer mutations caused by aberrant activation-induced cytidine deaminase activity. Taken together, our data support the hypothesis that differences in clinical outcome and biological characteristics between the two subgroups might reflect differences in mutation distribution, incidence and distinct underlying mutagenic mechanisms.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Burns A, Alsolami R, Becq J, et al. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups. Leukemia. 2017. PMID: 28584254. doi:10.1038/leu.2017.177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。